Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
HHS-NIH11
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus bro…
Alcohol Health Services Research (R01 Clinical Trial Optional)
HHS-NIH11
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing …
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
HHS-NIH11
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing …
Alcohol Health Services Research (R34 Clinical Trial Optional)
HHS-NIH11
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing …
State Occupational Safety and Health Surveillance Program (U60)
HHS-CDC-HHSCDCERA
NIOSH has established state surveillance programs broadly intended to: (1) Assess the extent and severity of workplace illnesses, injuries, exposures, and fatalities; (2) Identify workers and occupat…
National Community Anti-Drug Coalition Institute (NCI)
ONDCP
Adolescence is a critical risk period for substance use initiation and adverse outcomes related to substance use, particularly as drug use has been found to escalate between ages 12 and 19. The goal …
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based …
HHS-NIH11
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage cooperative agreement applications to support early stage clinical trials of novel mechanism of action, investigational drugs,…
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
HHS-NIH11
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot res…
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders …
HHS-NIH11
NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which studies both evaluate the clinical effect of an intervention and generate in…
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial …
HHS-NIH11
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required). As part of NIMH's clinical trials pipeline NOFOs, this announcement supp…
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
HHS-NIH11
This R61/R33 concept complements NIMHs suite of clinical trial NOFOs by supporting feasibility and infrastructure development (R61) followed by well-powered clinical trials (R33) to test the effectiv…
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
HHS-NIH11
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). As part of NIMH's clinical trials pipeline, this NOFO encourages pilot researc…